ArticleCephalalgia : an international journal of headache2021

Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons.

Agustin Melo-Carrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.